Status epilepticus: A review, with emphasis on refractory cases

Canadian Journal of Neurological Sciences

Volumn 39, Issue 2, 2012, Pages 157-169

  Hunter, Gary ^a   Young, G Bryan ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INHALATION ANESTHETIC AGENT; KETAMINE; LORAZEPAM; PHENYTOIN; VALPROIC ACID;

DISEASE CLASSIFICATION; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; GENERALIZED EPILEPSY; HUMAN; IMAGE ANALYSIS; INDUCED HYPOTHERMIA; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; OXYGENATION; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY STATUS EPILEPTICUS; REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 84857603249     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100013160     Document Type: Review

References (136)

1. Gastaut H, Roger J, Lob H. Les états de mal épileptique: compte rendu de la reunion européene d'information é lectroencéphalographique. Xth Colloque de Marseille, 1962. Masson, Paris.
2. Meldrum BS, Vigouroux RA, Brierley JB. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol. 1973 Aug;29(2): 82-7.
3. DeLorenzo RJ, Garnett LK, Towne AR, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999; 40: 164-9. (Pubitemid 29066300)
4. Theodore WH, Porter RJ, Albert P, et al. The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology. 1994; 44: 1403-7. (Pubitemid 24247426)
5. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. 1990 Jan-Feb; 5(1): 49-60. (Pubitemid 20046592)
6. Kaplan PW. EEG monitoring in the intensive care unit. Am J Electroneurodiagnostic Technol. 2006 Jun; 46(2): 81-97. (Pubitemid 43993099)
7. Goodman JH, Homan RW, Crawford IL. Kindled seizures activate both branches of the autonomic nervous system. Epilepsy Res. 1999; 34: 169-76. (Pubitemid 29155488)
8. Freeman R, Schachter SC. Autonomic epilepsy. Sem Neurol. 1995; 15: 158-66.
9. Baumgartner C, Lurger S, Leutmezer F. Autonomic symptoms during epileptic seizures. Epileptic Disord. 2001; 3(3): 103-16. (Pubitemid 32983184)
10. Oppenheimer SM, Gelb A, Girvin JP, et al. Cardiovascular effects of human insular cortex stimulation. Neurology. 1992; 42: 1727-32.
11. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002; 59(2): 205-10. (Pubitemid 34240935)
12. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005; 76(4): 534-9. (Pubitemid 40486579)
13. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005; 62(11): 1698-702. (Pubitemid 41626665)
14. Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Arch Neurol. 2005 Nov; 62 (11): 1698-702.
15. Hauser WA. Status epilepticus: epidemiology considerations. Neurology. 1990; 40 Suppl 2: 9-12.
16. DeLorenzo RJ, Towne AR, Ko D, et al. Prospective, populationbased epidemiological study of status epilepticus in Richmond VA. Neurology. 1996; 46: 1029-32.
17. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. N Eng J Med. 1998; 339: 792-8. (Pubitemid 28447452)
18. Towne AR, Pellock JM, Ko D, et al. Determinants of mortality in status epilepticus. Epilepsia. 1994;5:27-36.
19. Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia. 2009 Jun; 50(6): 1566-71.
20. Neligan A, Shorvon SD. Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review. Epilepsy Res. 2011; 93(1): 1-10.
21. Wasterlain CG, Liu H, Naylor DE, et al. Molecular basis of selfsustaining seizures and pharmacoresistance during status epilepticus: the receptor trafficking hypothesis revisited. Epilepsia 2009; 50 Suppl 12: 16-18.
22. Sperk G, Wieser R, Widmann R, Singer EA. Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin. Neuroscience. 1986; 17: 1117-26. (Pubitemid 16080100)
23. Wasterlain CG. Inhibition of cerebral protein synthesis by epileptic seizures without motor manifestations. Neurology. 1974; 24: 175-80.
24. Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABA-A receptors. J Neurosci. 1997; 17: 7532-40. (Pubitemid 27413283)
25. Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Timedependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res. 1998; 814: 179-85. (Pubitemid 29023424)
26. Bengzon J, Mohapel P, Ekdahl CT, Lindvall O. Neuronal apoptosis after brief and prolonged seizures. Prog Brain Res. 2002; 135: 111-19. (Pubitemid 35461010)
27. Sloviter RS, Dean E, Sollas AL, Goodman JH. Apoptosis and necrosis induced in different hippocampal neuron populations by repetitive perforant path stimulation in the rat. J Comp Neurol. 1996; 366(3): 516-33. (Pubitemid 26070617)
28. Ekdahl CT, Mohapel P, Elmér E, Lindvall O. Caspase inhibitors increase short-term survival of progenitor-cell progeny in the adult rat dentate gyrus following status epilepticus. Eur J Neurosci. 2001; 14(6): 937-45. (Pubitemid 35463767)
29. Cendes F, Andermann F, Carpenter S, Zatorre RJ, Cashman NR. Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor-mediated excitotoxicity in humans. Ann Neurol. 1995; 37: 123-6.
30. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-ofhospital status epilepticus. N Engl J Med. 2001; 345: 631-7.
31. Walker MC, Smith SJ, Shorvon SD. The intensive care treatment of convulsive status epilepticus in the UK: results of a national survey and recommendations. Anaesthesia. 1995; 50: 130-5.
32. Misra UK, Kalita J, Patel R. Sodium valproate vs. phenytoin in status epilepticus: a pilot study. Neurology. 2006 Jul 25; 67(2): 340-2. (Pubitemid 44313586)
33. Gilad R, Izkovitz N, Dabby R, et al. Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand. 2008; 118(5): 296-300.
34. Rossetti AO, Milligan TA, Vulliémoz S, Michaelides C, Bertschi M, Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care. 2011; 14(1): 4-10.
35. Minicucci F, Muscas G, Perucca E, Capovilla G, Vigevano F, Tinuper P. Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy. Epilepsia. 2006; 47 Suppl 5: 9-15. (Pubitemid 44924185)
36. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010; 17(3): 348-55.
37. Robakis TK, Hirsch LJ. Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care. 2006; 4(1): 35-46. (Pubitemid 43269460)
38. Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med. 2009; 37(12): 3024-30.
39. Zarovnaya EL, Jobst BC, Harris BT. Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. Epilepsia. 2007; 48(5): 1002-6. (Pubitemid 46763414)
40. Roberts RJ, Barletta JF, Fong JJ, et al. Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care. 2009; 13(5): R169.
41. Guitton C, Gabillet L, Latour P, et al. Propofol infusion syndrome during refractory status epilepticus in a young adult: successful ECMO resuscitation. Neurocrit Care. 2010 Aug;15(1):139-45.
42. Kassab MY, Lobeck IN, Majid A, Xie Y, Farooq MU. Blood pressure changes after intravenous fosphenytoin and levetiracetam in patients with acute cerebral symptoms. Epilepsy Res. 2009; 87(2-3): 268-71.
43. Fischer JH, Patel TV, Fischer PA. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokin. 2003; 42(1): 33-58. (Pubitemid 36092257)
44. Perrott J, Murphy NG, Zed PJ. L-carnitine for acute valproic acid overdose: a systematic review of published cases. Ann Pharmacother. 2010; 44(7-8): 1287-93.
45. Wang H, Gao J, Lassiter TF, et al. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit Care. 2006; 5(1): 71-8. (Pubitemid 44379157)
46. Eue S, Grumbt M, Müller M, Schulze A. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam. Epilepsy Behav. 2009; 15(4): 467-9.
47. Berning S, Boesebeck F, van Baalen A, Kellinghaus C. Intravenous levetiracetam as treatment for status epilepticus. J Neurol. 2009; 256(10): 1634-42.
48. Wasterlain CG, Chen JW. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia. 2008; 49 Suppl 9: 63-73.
49. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia. 2000;41 Suppl 2:S23-30. (Pubitemid 30387358)
50. Lundgren J, Smith ML, Blennow G, Siesjo BK. Hyperthermia aggravates and hypothermia ameliorates epileptic brain damage. Exp Brain Res. 1994; 99: 43-55. (Pubitemid 24169576)
51. Liu Z, Gatt A, Mikati M, Holmes GL. Effect of temperature on kainic acid-induced seizures. Brain Res. 1993; 631: 51-8. (Pubitemid 23351485)
52. Barry E, Hauser WA. Pleocytosis after status epilepticus. Arch Neurol. 1994; 51(2): 190-3. (Pubitemid 24051582)
53. Prokesch RC, Rimland D, Petrini JL Jr, FeinAB. Cerebrospinal fluid pleocytosis after seizures. South Med J. 1983; 76(3): 322-7.
54. Marik PE, Varon J. The management of status epilepticus. Chest. 2004; 126: 582-91. (Pubitemid 39093446)
55. Claassen J, Hirsch LJ, Emerson RG, et al. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology. 2001; 57: 1036-42. (Pubitemid 32880200)
56. Lepelletier D, Roquilly A, Demeure dit latte D, et al. Retrospective analysis of the risk factors and pathogens associated with earlyonset ventilator-associated pneumonia in surgical-ICU headtrauma patients. J Neurosurg Anesthesiol. 2010; 22(1): 32-7.
57. Bertram EH, Lothman EW. NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsants. Epilepsy Res. 1990; 5: 177-84. (Pubitemid 20125546)
58. Mazarati AM, Wasterlain CG. N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett. 1999; 265: 187-90. (Pubitemid 29207397)
59. Hsieh CY, Sung PS, Tsai JJ, Huang CW. Terminating prolonged refractory status epilepticus using ketamine. Clin Neuropharmacol. 2010; 33(3): 165-7.
60. Fujikawa DG. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia. 1995; 36(2): 186-95.
61. Bleck TP, Quogg M, Nathan BR, Smith TL, Kapur J. Electroencephalographic effects of ketamine treatment for refractory status epilepticus. Epilepsia. 2002; 43: 282.
62. Ko YY, Jeong YH, Lim DY. Influence of ketamine on catecholamine secretion in the perfused rat adrenal medulla. Korean J Physiol Pharmacol. 2008; 12(3): 101-9.
63. Ben Yehuda Y, Watemberg N. Ketamine increases opening cerebrospinal pressure in children undergoing lumbar puncture. J Child Neurol. 2006; 21(6): 441-3. (Pubitemid 44069790)
64. Martin BS, Kapur J. A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia. 2008; 49(2): 248-55. (Pubitemid 351171997)
65. Ubogu EE, Sagar SM, Lerner AJ, Maddux BN, Suarez JI, Werz MA. Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav. 2003; 4(1): 70-5. (Pubitemid 36546455)
66. Zou X, Patterson TA, Divine RL, et al. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci. 2009; 27(7): 727-31.
67. KofkeWA, Young RS, Davis P, et al. Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology. 1989; 71: 653-9. (Pubitemid 19275083)
68. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004; 61: 1254-9. (Pubitemid 39062680)
69. Ries CR, Puil E. Mechanism of action of anesthesia revealed by shunting actions of isoflurane on thalamocortical neurons. J Neurophysiol. 1999; 81: 1795-801. (Pubitemid 29262509)
70. Langmoen IA, Hegstad E, Berg-Johnsen J. An experimental study of the effect of isoflurane on epileptiform bursts. Epilepsy Res. 1992; 11: 153-7.
71. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anesthesia. Nature. 1994; 367: 607-14. (Pubitemid 24067700)
72. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G. Treatment of comatose survivors of out-ofhospital cardiac arrest with induced hypothermia. N Engl J Med. 2002 Feb 21; 346(8): 557-63. (Pubitemid 34438816)
73. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002 Feb 21; 346(8): 549-56.
74. Liu Z, Gatt A, Mikati M, Holmes GL. Effect of temperature on kainic acid-induced seizures. Brain Res. 1993;631(1):51-8. (Pubitemid 23351485)
75. Schmitt FC, Buchheim K, Meierkord H, Holtkamp M. Anticonvulsant properties of hypothermia in experimental status epilepticus. Neurobiol Dis. 2006; 23(3): 689-96. (Pubitemid 44234105)
76. Maeda T, Hashizume K, Tanaka T. Effect of hypothermia on kainic acid-induced limbic seizures: an electroencephalographic and 14C-deoxyglucose autoradiographic study. Brain Res. 1999; 818 (2): 228-35. (Pubitemid 29229936)
77. Corry JJ, Dhar R, Murphy T, Diringer MN. Hypothermia for refractory status epilepticus. Neurocrit Care. 2008; 9(2): 189-97.
78. Ng YT, Bristol RE, Schrader DV, Smith KA. The role of neurosurgery in status epilepticus. Neurocrit Care. 2007; 7(1): 86-91. (Pubitemid 350242686)
79. Schrader DV, Steinbok P, Connolly MB. Urgent resective surgery for refractory status epilepticus. Epilepsia. 2006; 47(S4): 149.
80. Costello DJ, Simon MV, Eskandar EN, et al. Efficacy of surgical treatment of de novo, adult-onset, cryptogenic, refractory focal status epilepticus. Arch Neurol. 2006; 63: 895-901. (Pubitemid 43882300)
81. Molyneux PD, Barker RA, Thom M, van Paesschen W, Harkness WF, Duncan JS. Successful treatment of intractable epilepsia partialis continua with multiple subpial transections. J Neurol Neurosurg Psychiatry. 1998; 65: 137-8. (Pubitemid 28302379)
82. D'Giano CH, Del CG, Pomata H, Rabinowicz. Treatment of refractory partial status epilepticus with multiple subpial transection: case report. Seizure. 2001; 10: 382-5. (Pubitemid 32755364)
83. Bristol RE, Gore P, Treiman D, Smith KA. Resolution of status epilepticus after subdural grid recording and multiple subpial transections. Barrow Quarterly. 2006; 22: 8-11.
84. Ng YT, Kim HL, Wheless JW. Successful neurosurgical treatment of childhood complex partial status epilepticus by focal resection. Epilepsia. 2003; 44: 468-71. (Pubitemid 36343781)
85. Duane DC, Ng YT, Rekate HL, Chung S, Bodensteiner JB, Kerrigan JF. Treatment of refractory status epilepticus with hemispherectomy. Epilepsia. 2004; 45: 1001-4. (Pubitemid 39062828)
86. Winston KR, Levisohn P, Miller BR, Freeman J. Vagal nerve stimulation for status epilepticus. Pediatr Neurosurg. 2001; 34: 190-2. (Pubitemid 32453749)
87. Patwardhan RV, Dellabadia J Jr, Rashidi M, Grier L, Nanda A. Control of refractory status epilepticus precipitated by anticonvulsant withdrawal using left vagal nerve stimulation: a case report. Surg Neurol. 2005; 64: 170-3. (Pubitemid 41051023)
88. Carrasco G, Palomar M, Rovira R. Electroconvulsive therapy for status epilepticus. Ann Intern Med. 1997; 127: 247-8.
89. Griesemer DA, Kellner CH, Beale MD, Smith GM. Electroconvulsive therapy for treatment of intractable seizures. Initial findings in two children. Neurology. 1997; 49: 1389-92. (Pubitemid 27495648)
90. Lisanby SH, Bazil CW, Resor SR, Nobler MS, Finck DA, Sackeim HA. ECT in the treatment of status epilepticus. J ECT. 2001; 17: 210-15. (Pubitemid 32831380)
91. Cline JS, Roos K. Treatment of status epilepticus with electroconvulsive therapy. J ECT. 2007; 23: 30-2. (Pubitemid 46673531)
92. Kamel H, Cornes SB, Hegde M, Hall SE, Josephson SA. Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care. 2010; 12(2): 204-10.
93. Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J ECT. 1999; 15(1): 5-26. (Pubitemid 29318091)
94. Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004; 62(10): 1743-8. (Pubitemid 38661728)
95. Young GB, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology. 1996; 47(1): 83-9. (Pubitemid 26243864)
96. Young GB, Jordan KG. Do nonconvulsive seizures damage the brain? - Yes. Arch Neurol. 1998; 55(1): 117-19. (Pubitemid 28139113)
97. Brandt C, Glien M, Potschka H, Volk H, Löscher W. Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats. Epilepsy Res. 2003; 55(1-2): 83-103. (Pubitemid 37011375)
98. Bengzon J, Mohapel P, Ekdahl CT, Lindvall O. Neuronal apoptosis after brief and prolonged seizures. Prog Brain Res. 2002; 135: 111-19. (Pubitemid 35461010)
99. Mikulecká A, Krsek P, Hlinák Z, Druga R, Mares P. Nonconvulsive status epilepticus in rats: impaired responsiveness to exteroceptive stimuli. Behav Brain Res. 2000; 117(1-2): 29-39.
100. Nevander G, Ingvar M, Auer R, Siesjö BK. Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol. 1985; 18(3): 281-90. (Pubitemid 15023100)
101. Krsek P, Mikulecká A, Druga R, et al. Long-term behavioral and morphological consequences of nonconvulsive status epilepticus in rats. Epilepsy Behav. 2004; 5(2): 180-91. (Pubitemid 38468564)
102. Young GB, Campbell VC. EEG monitoring in the intensive care unit: pitfalls and caveats. J Clin Neurophysiol. 1999; 16(1): 40-5. (Pubitemid 29096030)
103. Sigl JC, Chamoun NG. An introduction to bispectral analysis for the electroencephalogram. J Clin Monit. 1994; 10(6): 392-404. (Pubitemid 24354607)
104. Hasselman K, Munk W, MacDonald G. Bispectra of ocean waves. In: Rosenblatt M, editor. Time series analysis. New York: John Wiley and Sons; 1963. p. 125-39.
105. Haubrich RA. Earth noise, 5 to 500 millicycles per second. J Geophys Res. 1965; 70: 1415-27.
106. Tallach RE, Ball DR, Jefferson P. Monitoring seizures with the Bispectral index. Anaesthesia. 2004; 59(10): 1033-4.
107. Dahaba AA, Liu DW, Metzler H. Bispectral index (BIS) monitoring of acute encephalitis with refractory, repetitive partial seizures (AERRPS). Minerva Anestesiol. 2010; 76(4): 298-301.
108. Bridgers SL, Ebersole JS. EEG outside the hairline: detection of epileptiform abnormalities. Neurology. 1988; 38(1): 146-9. (Pubitemid 18028111)
109. Young GB, Sharpe MD, Savard M, Al Thenayan E, Norton L, Davies-Schinkel C. Seizure detection with a commercially available bedside EEG monitor and the subhairline montage. Neurocrit Care. 2009; 11(3): 411-16.
110. Karakis I, Montouris GD, Otis JA, Douglass LM, Jonas R, Velez- Ruiz N. A quick and reliable EEG montage for the detection of seizures in the critical care setting. J Clin Neurophysiol. 2010; 27(2): 100-5.
111. Task Force of the Canadian Society of Clinical Neurophysiologists. Minimal standards for electroencephalography in Canada. Can J Neurol Sci. 2002; 29(3): 216-20.
112. Boulanger JM, Deacon C, Lécuyer D, Gosselin S, Reiher J. Triphasic waves versus nonconvulsive status epilepticus: EEG distinction. Can J Neurol Sci. 2006; 33(2): 175-80. (Pubitemid 43845170)
113. Dalmau J, Tüzün E,Wu HY, et al. Paraneoplastic anti-N-methyl-Daspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007; 61(1): 25-36. (Pubitemid 46214241)
114. Thieben MJ, Lennon VA, Boeve BF, et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004; 62(7): 1177-82. (Pubitemid 38456513)
115. Wall CJ, Kendall EJ, Obenaus A. Rapid alterations in diffusionweighted images with anatomic correlates in a rodent model of status epilepticus.AJNRAmJ Neuroradiol. 2000; 21(10): 1841-52.
116. Engelhorn T, Hufnagel A, Weise J, Baehr M, Doerfler A. Monitoring of acute generalized status epilepticus using multilocal diffusion MR imaging: early prediction of regional neuronal damage. AJNR Am J Neuroradiol. 2007; 28(2): 321-7. (Pubitemid 46281056)
117. Katramados AM, Burdette D, Patel SC, Schultz LR, Gaddam S, Mitsias PD. Periictal diffusion abnormalities of the thalamus in partial status epilepticus. Epilepsia. 2009; 50: 265-75.
118. Boyd JG, Taylor S, Rossiter JP, Islam O, Spiller A, Brunet DG. New-onset refractory status epilepticus with restricted DWI and neuronophagia in the pulvinar. Neurology. 2010; 74(12): 1003-5.
119. Milligan TA, Zamani A, Bromfield E. Frequency and patterns of MRI abnormalities due to status epilepticus. Seizure. 2009; 18 (2): 104-8.
120. Di Bonaventura C, Bonini F, Fattouch J, et al. Diffusion-weighted magnetic resonance imaging in patients with partial status epilepticus. Epilepsia. 2009; 50 Suppl 1: 45-52.
121. Grommes C, Oghlakian R, Blackham KA, De Georgia MA. Corpus callosum dysgenesis limits MRI changes to one hemisphere in status epilepticus. Neurology. 2009; 72(10): 942.
122. Canas N, Soares P, Calado S, Pestana R, Ribeiro C, Vale J. Pathophysiology and long-term outcome of reversible tumorlike lesions induced by presenting status epilepticus. J Neuroimaging. 2010; 20(2): 169-74.
123. van Eijsden P, Otte WM, van der Hel WS, et al. In vivo diffusion tensor imaging and ex vivo histologic characterization of white matter pathology in a post-status epilepticus model of temporal lobe epilepsy. Epilepsia. 2011; 52(4): 841-5.
124. Kawahara I, Tsutsumi K, Hirose M, Matsuo Y, Yokoyama H. Transient abnormalities associated with status epilepticus on diffusion-weighted MR imaging. No To Shinkei. 2004; 56(4): 333-8. (Pubitemid 38855775)
125. Urbach H, Soeder BM, Jeub M, Klockgether T, Meyer B, Bien CG. Serial MRI of limbic encephalitis. Neuroradiology. 2006; 48(6): 380-6. (Pubitemid 43923159)
126. Bonita R, Beaglehole R. "Modification of Rankin Scale: Recovery of motor function after stroke." Stroke. 1988; 19(12): 1497-500. (Pubitemid 19005804)
127. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975; 1(7905): 480-4.
128. Treiman DM, Delgado-Escueta AV, Clark MA. Impairment of memory following complex partial status epilepticus. Neurology. 1981; 31: 109.
129. Kitagawa T, Takahashi K, Matsushima K, Kawahara R. A case of prolonged confusion after temporal lobe psychomotor status. Folia Psychiatr Neurol. 1989; 33: 279-84.
130. Adachi N, Kanemoto K, Muramatsu R, et al. Intellectual prognosis of status epilepticus in adult epilepsy patients: analysis with Wechsler Adult Intelligence Scale-revised. Epilepsia. 2005; 46 (9): 1502-9.
131. Wilder-Smith EP, Lim EC, Teoh HL, et al. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med. Singapore. 2005; 34(7): 417-20. (Pubitemid 41290847)
132. Van Lierde I, Van Paesschen W, Dupont P, Maes A, Sciot R. De novo cryptogenic refractory multifocal febrile status epilepticus in the young adult: a review of six cases. Acta Neurol Belg. 2003; 103(2): 88-94. (Pubitemid 36834074)
133. Hoerth MT, Sirven JI, Drazkowski JF, Noe KH. Malignant status epilepticus syndrome: refractory idiopathic status epilepticus. Epilepsia. 2007; 48(S6): P012.
134. Costello DJ, Kilbride RD, Cole AJ. Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-Infectious or not? J Neurol Sci. 2009; 277(1-2): 26-31.
135. Kanter IC, Huttner HB, Staykov D, et al. Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia. 2008; 49(5): 914-20. Epub 2007 Dec 28. (Pubitemid 351652431)
136. Shorvon S, Tan R. Uncommon causes of status epilepticus. Epilepsia. 2009; 50 Suppl 12: 61-3.